| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural molecule activity | COL3A1 COL5A2 KRT31 KRT32 KRT35 KRTAP3-1 LAMA2 LAMA5 LAMC1 LTBP1 KRTAP16-1 SSPOP KRT38 KRT36 | 6.84e-06 | 891 | 77 | 14 | GO:0005198 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 8.09e-06 | 188 | 77 | 7 | GO:0005201 | |
| GeneOntologyMolecularFunction | transforming growth factor beta receptor activity | 1.53e-05 | 13 | 77 | 3 | GO:0005024 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein serine/threonine kinase activity | 6.00e-05 | 20 | 77 | 3 | GO:0004675 | |
| GeneOntologyMolecularFunction | Fc-gamma receptor I complex binding | 3.04e-04 | 7 | 77 | 2 | GO:0034988 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein kinase activity | 3.27e-04 | 85 | 77 | 4 | GO:0019199 | |
| GeneOntologyMolecularFunction | arylsulfatase activity | 1.30e-03 | 14 | 77 | 2 | GO:0004065 | |
| GeneOntologyBiologicalProcess | skin development | COL3A1 COL5A2 SPRR2D SPRR2G SPRR4 LAMA5 LAMC1 LCE2D LCE2C KRT36 LCE3B LCE3A NOTCH1 LCE7A LCE2A LCE2B | 8.94e-13 | 373 | 80 | 16 | GO:0043588 |
| GeneOntologyBiologicalProcess | keratinization | SPRR2D SPRR2G SPRR4 LCE2D LCE2C LCE3B LCE3A LCE7A LCE2A LCE2B | 1.35e-12 | 87 | 80 | 10 | GO:0031424 |
| GeneOntologyBiologicalProcess | epidermis development | KRT31 KRT32 SPRR2D SPRR2G SPRR4 LAMA5 LAMC1 SLITRK6 LCE2D LCE2C KRT36 LCE3B LCE3A NOTCH1 LCE7A LCE2A LCE2B | 1.80e-12 | 461 | 80 | 17 | GO:0008544 |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | SPRR2D SPRR2G SPRR4 LAMC1 SLITRK6 LCE2D LCE2C KRT36 LCE3B LCE3A NOTCH1 LCE7A LCE2A LCE2B | 4.28e-12 | 284 | 80 | 14 | GO:0009913 |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | SPRR2D SPRR2G SPRR4 LCE2D LCE2C KRT36 LCE3B LCE3A NOTCH1 LCE7A LCE2A LCE2B | 8.63e-12 | 189 | 80 | 12 | GO:0030216 |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | FNDC3B KRT31 KRT32 KRT35 SPRR2D SPRR2G SPRR4 CHRD LAMC1 ACVR1 SLITRK6 KRT38 LCE2D LCE2C KRT36 LCE3B LCE3A NOTCH1 LCE7A LCE2A LCE2B | 1.01e-11 | 870 | 80 | 21 | GO:0030855 |
| GeneOntologyBiologicalProcess | epithelium development | WDR19 FNDC3B NFATC1 KRT31 KRT32 KRT35 SPRR2D SPRR2G SPRR4 CHRD LAMA5 LAMC1 ACVR1 SLITRK6 KRT38 LCE2D LCE2C KRT36 LCE3B LCE3A NOTCH1 LCE7A LCE2A LCE2B | 8.04e-10 | 1469 | 80 | 24 | GO:0060429 |
| GeneOntologyBiologicalProcess | intermediate filament organization | 1.08e-05 | 75 | 80 | 5 | GO:0045109 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 4.16e-05 | 99 | 80 | 5 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 4.37e-05 | 100 | 80 | 5 | GO:0045103 | |
| GeneOntologyBiologicalProcess | digestive system development | 4.72e-05 | 167 | 80 | 6 | GO:0055123 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 5.59e-05 | 445 | 80 | 9 | GO:0141091 | |
| GeneOntologyBiologicalProcess | epithelial cell fate commitment | 6.11e-05 | 20 | 80 | 3 | GO:0072148 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 1.03e-04 | 482 | 80 | 9 | GO:0007178 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 1.18e-04 | 197 | 80 | 6 | GO:0030509 | |
| GeneOntologyBiologicalProcess | artery development | 1.69e-04 | 133 | 80 | 5 | GO:0060840 | |
| GeneOntologyBiologicalProcess | response to BMP | 1.89e-04 | 215 | 80 | 6 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 1.89e-04 | 215 | 80 | 6 | GO:0071773 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 2.04e-04 | 218 | 80 | 6 | GO:0090101 | |
| GeneOntologyBiologicalProcess | endocardial cell differentiation | 2.21e-04 | 6 | 80 | 2 | GO:0060956 | |
| GeneOntologyBiologicalProcess | aorta development | 2.65e-04 | 80 | 80 | 4 | GO:0035904 | |
| GeneOntologyBiologicalProcess | digestive tract development | 3.14e-04 | 152 | 80 | 5 | GO:0048565 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 3.20e-04 | 84 | 80 | 4 | GO:1903053 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 3.98e-04 | 347 | 80 | 7 | GO:0090092 | |
| GeneOntologyBiologicalProcess | positive regulation of type I hypersensitivity | 4.10e-04 | 8 | 80 | 2 | GO:0001812 | |
| GeneOntologyBiologicalProcess | cardiac endothelial cell differentiation | 4.10e-04 | 8 | 80 | 2 | GO:0003348 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoblast differentiation | 4.16e-04 | 90 | 80 | 4 | GO:0045668 | |
| GeneOntologyBiologicalProcess | ventricular septum development | 4.34e-04 | 91 | 80 | 4 | GO:0003281 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 4.52e-04 | 92 | 80 | 4 | GO:0048844 | |
| GeneOntologyBiologicalProcess | positive regulation of cardiac epithelial to mesenchymal transition | 5.25e-04 | 9 | 80 | 2 | GO:0062043 | |
| GeneOntologyBiologicalProcess | regulation of type I hypersensitivity | 5.25e-04 | 9 | 80 | 2 | GO:0001810 | |
| GeneOntologyBiologicalProcess | cell adhesion involved in heart morphogenesis | 5.25e-04 | 9 | 80 | 2 | GO:0061343 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 6.20e-04 | 43 | 80 | 3 | GO:0071711 | |
| GeneOntologyBiologicalProcess | positive regulation of type IIa hypersensitivity | 6.55e-04 | 10 | 80 | 2 | GO:0001798 | |
| GeneOntologyBiologicalProcess | type I hypersensitivity | 6.55e-04 | 10 | 80 | 2 | GO:0016068 | |
| GeneOntologyBiologicalProcess | positive regulation of type II hypersensitivity | 6.55e-04 | 10 | 80 | 2 | GO:0002894 | |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 6.64e-04 | 44 | 80 | 3 | GO:0006958 | |
| GeneOntologyBiologicalProcess | regulation of type IIa hypersensitivity | 7.99e-04 | 11 | 80 | 2 | GO:0001796 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 7.99e-04 | 11 | 80 | 2 | GO:0110011 | |
| GeneOntologyBiologicalProcess | regulation of type II hypersensitivity | 7.99e-04 | 11 | 80 | 2 | GO:0002892 | |
| GeneOntologyBiologicalProcess | mature B cell differentiation | 8.06e-04 | 47 | 80 | 3 | GO:0002335 | |
| GeneOntologyBiologicalProcess | axon guidance | 8.43e-04 | 285 | 80 | 6 | GO:0007411 | |
| GeneOntologyBiologicalProcess | substrate adhesion-dependent cell spreading | 8.57e-04 | 109 | 80 | 4 | GO:0034446 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 8.58e-04 | 286 | 80 | 6 | GO:0097485 | |
| GeneOntologyBiologicalProcess | regulation of osteoblast differentiation | 9.07e-04 | 192 | 80 | 5 | GO:0045667 | |
| GeneOntologyBiologicalProcess | mesenchymal cell differentiation | 1.03e-03 | 296 | 80 | 6 | GO:0048762 | |
| GeneOntologyBiologicalProcess | cell recognition | 1.04e-03 | 198 | 80 | 5 | GO:0008037 | |
| GeneOntologyBiologicalProcess | B cell differentiation | 1.11e-03 | 201 | 80 | 5 | GO:0030183 | |
| GeneOntologyBiologicalProcess | endocardium development | 1.13e-03 | 13 | 80 | 2 | GO:0003157 | |
| GeneOntologyBiologicalProcess | antibody-dependent cellular cytotoxicity | 1.13e-03 | 13 | 80 | 2 | GO:0001788 | |
| GeneOntologyBiologicalProcess | venous blood vessel morphogenesis | 1.13e-03 | 13 | 80 | 2 | GO:0048845 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | WDR19 COL3A1 COL5A2 NFATC1 FAT3 MUC19 LAMA2 LAMA5 LAMC1 ROM1 ACVR1 SLITRK6 NOTCH1 | 1.13e-03 | 1269 | 80 | 13 | GO:0009887 |
| GeneOntologyBiologicalProcess | cell killing | 1.24e-03 | 307 | 80 | 6 | GO:0001906 | |
| GeneOntologyBiologicalProcess | vasculature development | COL3A1 EPHB3 AMHR2 NFATC1 CHRD ROM1 LTBP1 ACVR1 RECK NOTCH1 NOTCH3 | 1.25e-03 | 969 | 80 | 11 | GO:0001944 |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 1.31e-03 | 14 | 80 | 2 | GO:2001046 | |
| GeneOntologyBiologicalProcess | regulation of cardiac epithelial to mesenchymal transition | 1.31e-03 | 14 | 80 | 2 | GO:0062042 | |
| GeneOntologyBiologicalProcess | ventricular septum morphogenesis | 1.34e-03 | 56 | 80 | 3 | GO:0060412 | |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 1.38e-03 | 124 | 80 | 4 | GO:0007229 | |
| GeneOntologyBiologicalProcess | endocardial cushion development | 1.49e-03 | 58 | 80 | 3 | GO:0003197 | |
| GeneOntologyBiologicalProcess | mitral valve morphogenesis | 1.51e-03 | 15 | 80 | 2 | GO:0003183 | |
| GeneOntologyBiologicalProcess | type IIa hypersensitivity | 1.51e-03 | 15 | 80 | 2 | GO:0001794 | |
| GeneOntologyBiologicalProcess | positive regulation of hypersensitivity | 1.51e-03 | 15 | 80 | 2 | GO:0002885 | |
| GeneOntologyBiologicalProcess | type II hypersensitivity | 1.51e-03 | 15 | 80 | 2 | GO:0002445 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.57e-03 | 566 | 80 | 8 | GO:0007409 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | COL3A1 AMHR2 CHRDL2 NFATC1 KCP CHRD LTBP1 ACVR1 HTRA4 NOTCH1 | 1.62e-03 | 850 | 80 | 10 | GO:0071363 |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 1.69e-03 | 131 | 80 | 4 | GO:0030510 | |
| GeneOntologyBiologicalProcess | mitral valve development | 1.72e-03 | 16 | 80 | 2 | GO:0003174 | |
| GeneOntologyBiologicalProcess | complement-dependent cytotoxicity | 1.72e-03 | 16 | 80 | 2 | GO:0097278 | |
| GeneOntologyBiologicalProcess | limb development | 1.79e-03 | 224 | 80 | 5 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 1.79e-03 | 224 | 80 | 5 | GO:0048736 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 1.80e-03 | 62 | 80 | 3 | GO:0002455 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 1.84e-03 | 134 | 80 | 4 | GO:0003279 | |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 1.89e-03 | 63 | 80 | 3 | GO:0003179 | |
| GeneOntologyBiologicalProcess | epigenetic programming in the zygotic pronuclei | 1.95e-03 | 17 | 80 | 2 | GO:0044725 | |
| GeneOntologyBiologicalProcess | positive regulation of acute inflammatory response to antigenic stimulus | 1.95e-03 | 17 | 80 | 2 | GO:0002866 | |
| GeneOntologyBiologicalProcess | cellular response to transforming growth factor beta stimulus | 1.95e-03 | 336 | 80 | 6 | GO:0071560 | |
| GeneOntologyBiologicalProcess | response to growth factor | COL3A1 AMHR2 CHRDL2 NFATC1 KCP CHRD LTBP1 ACVR1 HTRA4 NOTCH1 | 2.15e-03 | 883 | 80 | 10 | GO:0070848 |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 2.17e-03 | 343 | 80 | 6 | GO:0090596 | |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | 2.17e-03 | 343 | 80 | 6 | GO:0071559 | |
| GeneOntologyCellularComponent | intermediate filament | KRTAP2-3 KRT31 KRT32 KRT35 KRTAP2-4 KRTAP3-1 KRTAP2-1 KRTAP16-1 KRT38 KRT36 KRTAP10-4 KRTAP10-6 | 5.42e-11 | 227 | 79 | 12 | GO:0005882 |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRTAP2-3 KRT31 KRT32 KRT35 KRTAP2-4 KRTAP3-1 KRTAP2-1 KRTAP16-1 KRT38 KRT36 KRTAP10-4 KRTAP10-6 | 2.97e-10 | 263 | 79 | 12 | GO:0045111 |
| GeneOntologyCellularComponent | keratin filament | KRTAP2-3 KRTAP2-4 KRTAP3-1 KRTAP2-1 KRTAP16-1 KRT36 KRTAP10-4 KRTAP10-6 | 3.19e-09 | 97 | 79 | 8 | GO:0045095 |
| GeneOntologyCellularComponent | supramolecular fiber | COL3A1 KRTAP2-3 COL5A2 KRT31 KRT32 KRT35 KRTAP2-4 KRTAP3-1 KRTAP2-1 LTBP1 ODF1 KRTAP16-1 KRT38 KRT36 KRTAP10-4 KRTAP10-6 | 7.04e-06 | 1179 | 79 | 16 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | COL3A1 KRTAP2-3 COL5A2 KRT31 KRT32 KRT35 KRTAP2-4 KRTAP3-1 KRTAP2-1 LTBP1 ODF1 KRTAP16-1 KRT38 KRT36 KRTAP10-4 KRTAP10-6 | 7.67e-06 | 1187 | 79 | 16 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRTAP2-3 KRT31 KRT32 KRT35 KRTAP2-4 KRTAP3-1 KRTAP2-1 ODF1 KRTAP16-1 KRT38 KRT36 KRTAP10-4 KRTAP10-6 | 3.00e-05 | 899 | 79 | 13 | GO:0099513 |
| GeneOntologyCellularComponent | extracellular matrix | COL3A1 COL5A2 LAMB4 FCGBP ZAN LAMA2 LAMA5 LAMC1 MUC5B LTBP1 SSPOP | 3.48e-05 | 656 | 79 | 11 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL3A1 COL5A2 LAMB4 FCGBP ZAN LAMA2 LAMA5 LAMC1 MUC5B LTBP1 SSPOP | 3.58e-05 | 658 | 79 | 11 | GO:0030312 |
| GeneOntologyCellularComponent | laminin-10 complex | 4.22e-05 | 3 | 79 | 2 | GO:0043259 | |
| GeneOntologyCellularComponent | laminin-11 complex | 4.22e-05 | 3 | 79 | 2 | GO:0043260 | |
| GeneOntologyCellularComponent | synaptic cleft | 2.61e-04 | 33 | 79 | 3 | GO:0043083 | |
| GeneOntologyCellularComponent | laminin complex | 6.22e-04 | 10 | 79 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 8.72e-04 | 530 | 79 | 8 | GO:0062023 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 9.08e-04 | 12 | 79 | 2 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 9.08e-04 | 12 | 79 | 2 | GO:0098643 | |
| GeneOntologyCellularComponent | basement membrane | 1.18e-03 | 122 | 79 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | IgG immunoglobulin complex | 1.25e-03 | 14 | 79 | 2 | GO:0071735 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.61e-03 | 332 | 79 | 6 | GO:0005788 | |
| GeneOntologyCellularComponent | immunoglobulin complex, circulating | 1.85e-03 | 17 | 79 | 2 | GO:0042571 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 1.85e-03 | 17 | 79 | 2 | GO:0098637 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 2.83e-03 | 21 | 79 | 2 | GO:0098644 | |
| MousePheno | abnormal basement membrane morphology | 1.76e-05 | 40 | 55 | 4 | MP:0004272 | |
| Domain | VWC | COL3A1 COL5A2 FCGBP CHRDL2 ZAN PXDNL MUC19 KCP CHRD MUC5B SSPOP | 4.12e-18 | 38 | 79 | 11 | SM00214 |
| Domain | SPRR/LCE | 1.25e-17 | 28 | 79 | 10 | IPR026075 | |
| Domain | VWF_dom | COL3A1 COL5A2 FCGBP CHRDL2 ZAN PXDNL MUC19 KCP CHRD MUC5B SSPOP | 1.45e-17 | 42 | 79 | 11 | IPR001007 |
| Domain | VWFC_2 | 4.36e-16 | 38 | 79 | 10 | PS50184 | |
| Domain | VWFC_1 | 2.33e-14 | 36 | 79 | 9 | PS01208 | |
| Domain | Unchr_dom_Cys-rich | 7.91e-12 | 13 | 79 | 6 | IPR014853 | |
| Domain | C8 | 7.91e-12 | 13 | 79 | 6 | SM00832 | |
| Domain | TIL_dom | 1.38e-11 | 14 | 79 | 6 | IPR002919 | |
| Domain | VWC | 2.03e-11 | 28 | 79 | 7 | PF00093 | |
| Domain | VWD | 3.65e-11 | 16 | 79 | 6 | SM00216 | |
| Domain | VWF_type-D | 3.65e-11 | 16 | 79 | 6 | IPR001846 | |
| Domain | VWFD | 3.65e-11 | 16 | 79 | 6 | PS51233 | |
| Domain | VWD | 3.65e-11 | 16 | 79 | 6 | PF00094 | |
| Domain | LCE | 5.63e-11 | 17 | 79 | 6 | PF14672 | |
| Domain | LCE | 5.63e-11 | 17 | 79 | 6 | IPR028205 | |
| Domain | VWC_out | 1.23e-10 | 19 | 79 | 6 | SM00215 | |
| Domain | TIL | 9.21e-10 | 12 | 79 | 5 | PF01826 | |
| Domain | C8 | 9.21e-10 | 12 | 79 | 5 | PF08742 | |
| Domain | EGF_1 | 1.19e-07 | 255 | 79 | 10 | PS00022 | |
| Domain | KAP | 1.60e-07 | 58 | 79 | 6 | IPR002494 | |
| Domain | EGF_2 | 1.70e-07 | 265 | 79 | 10 | PS01186 | |
| Domain | Growth_fac_rcpt_ | 3.12e-07 | 156 | 79 | 8 | IPR009030 | |
| Domain | Laminin_N | 5.19e-07 | 16 | 79 | 4 | IPR008211 | |
| Domain | LAMININ_NTER | 5.19e-07 | 16 | 79 | 4 | PS51117 | |
| Domain | Laminin_N | 5.19e-07 | 16 | 79 | 4 | PF00055 | |
| Domain | LamNT | 5.19e-07 | 16 | 79 | 4 | SM00136 | |
| Domain | EGF | 6.49e-07 | 235 | 79 | 9 | SM00181 | |
| Domain | Keratin_B2 | 6.98e-07 | 40 | 79 | 5 | PF01500 | |
| Domain | EGF-like_dom | 1.05e-06 | 249 | 79 | 9 | IPR000742 | |
| Domain | Keratin_I | 1.14e-06 | 44 | 79 | 5 | IPR002957 | |
| Domain | EGF-like_CS | 1.55e-06 | 261 | 79 | 9 | IPR013032 | |
| Domain | LAMININ_IVA | 4.02e-06 | 8 | 79 | 3 | PS51115 | |
| Domain | Laminin_B | 4.02e-06 | 8 | 79 | 3 | PF00052 | |
| Domain | LamB | 4.02e-06 | 8 | 79 | 3 | SM00281 | |
| Domain | Laminin_IV | 4.02e-06 | 8 | 79 | 3 | IPR000034 | |
| Domain | Intermediate_filament_CS | 6.91e-06 | 63 | 79 | 5 | IPR018039 | |
| Domain | EGF_LAM_2 | 7.47e-06 | 30 | 79 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 7.47e-06 | 30 | 79 | 4 | PS01248 | |
| Domain | Filament | 1.25e-05 | 71 | 79 | 5 | SM01391 | |
| Domain | IF | 1.34e-05 | 72 | 79 | 5 | PS00226 | |
| Domain | Laminin_EGF | 1.40e-05 | 35 | 79 | 4 | PF00053 | |
| Domain | EGF_Lam | 1.40e-05 | 35 | 79 | 4 | SM00180 | |
| Domain | Filament | 1.43e-05 | 73 | 79 | 5 | PF00038 | |
| Domain | IF | 1.74e-05 | 76 | 79 | 5 | IPR001664 | |
| Domain | Laminin_EGF | 1.96e-05 | 38 | 79 | 4 | IPR002049 | |
| Domain | Galactose-bd-like | 4.87e-05 | 94 | 79 | 5 | IPR008979 | |
| Domain | TILa | 5.29e-05 | 3 | 79 | 2 | PF12714 | |
| Domain | ZnF_NFX | 5.29e-05 | 3 | 79 | 2 | SM00438 | |
| Domain | TILa_dom | 5.29e-05 | 3 | 79 | 2 | IPR025615 | |
| Domain | DUF3454 | 5.29e-05 | 3 | 79 | 2 | PF11936 | |
| Domain | DUF3454_notch | 5.29e-05 | 3 | 79 | 2 | IPR024600 | |
| Domain | zf-NF-X1 | 5.29e-05 | 3 | 79 | 2 | PF01422 | |
| Domain | Znf_NFX1 | 5.29e-05 | 3 | 79 | 2 | IPR000967 | |
| Domain | DUF3454 | 5.29e-05 | 3 | 79 | 2 | SM01334 | |
| Domain | CTCK_1 | 5.68e-05 | 18 | 79 | 3 | PS01185 | |
| Domain | Notch | 1.05e-04 | 4 | 79 | 2 | IPR008297 | |
| Domain | NODP | 1.05e-04 | 4 | 79 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 1.05e-04 | 4 | 79 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 1.05e-04 | 4 | 79 | 2 | IPR010660 | |
| Domain | NOD | 1.05e-04 | 4 | 79 | 2 | PF06816 | |
| Domain | NOD | 1.05e-04 | 4 | 79 | 2 | SM01338 | |
| Domain | NODP | 1.05e-04 | 4 | 79 | 2 | SM01339 | |
| Domain | Cys_knot_C | 1.57e-04 | 25 | 79 | 3 | IPR006207 | |
| Domain | CTCK_2 | 1.57e-04 | 25 | 79 | 3 | PS01225 | |
| Domain | Laminin_aI | 1.75e-04 | 5 | 79 | 2 | IPR009254 | |
| Domain | Laminin_I | 1.75e-04 | 5 | 79 | 2 | PF06008 | |
| Domain | Laminin_II | 1.75e-04 | 5 | 79 | 2 | PF06009 | |
| Domain | Laminin_domII | 1.75e-04 | 5 | 79 | 2 | IPR010307 | |
| Domain | LNR | 1.75e-04 | 5 | 79 | 2 | PS50258 | |
| Domain | - | 2.59e-04 | 73 | 79 | 4 | 2.60.120.260 | |
| Domain | SPRR2 | 2.62e-04 | 6 | 79 | 2 | IPR029142 | |
| Domain | SPRR2 | 2.62e-04 | 6 | 79 | 2 | PF14820 | |
| Domain | Notch_dom | 3.66e-04 | 7 | 79 | 2 | IPR000800 | |
| Domain | Notch | 3.66e-04 | 7 | 79 | 2 | PF00066 | |
| Domain | NL | 3.66e-04 | 7 | 79 | 2 | SM00004 | |
| Domain | EGF_3 | 4.81e-04 | 235 | 79 | 6 | PS50026 | |
| Domain | EGF_CA | 4.84e-04 | 86 | 79 | 4 | PF07645 | |
| Domain | LAM_G_DOMAIN | 5.52e-04 | 38 | 79 | 3 | PS50025 | |
| Domain | Keratin_B2_2 | 5.96e-04 | 39 | 79 | 3 | PF13885 | |
| Domain | Laminin_G_2 | 6.43e-04 | 40 | 79 | 3 | PF02210 | |
| Domain | EGF_Ca-bd_CS | 7.62e-04 | 97 | 79 | 4 | IPR018097 | |
| Domain | Activin_recp | 7.78e-04 | 10 | 79 | 2 | IPR000472 | |
| Domain | Activin_recp | 7.78e-04 | 10 | 79 | 2 | PF01064 | |
| Domain | EGF_CA | 8.23e-04 | 99 | 79 | 4 | PS01187 | |
| Domain | LamG | 8.51e-04 | 44 | 79 | 3 | SM00282 | |
| Domain | ASX_HYDROXYL | 8.55e-04 | 100 | 79 | 4 | PS00010 | |
| Domain | Fib_collagen_C | 9.48e-04 | 11 | 79 | 2 | IPR000885 | |
| Domain | COLFI | 9.48e-04 | 11 | 79 | 2 | PF01410 | |
| Domain | NC1_FIB | 9.48e-04 | 11 | 79 | 2 | PS51461 | |
| Domain | Fib_collagen_C | 9.48e-04 | 11 | 79 | 2 | PD002078 | |
| Domain | COLFI | 9.48e-04 | 11 | 79 | 2 | SM00038 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.06e-03 | 106 | 79 | 4 | IPR000152 | |
| Domain | TGFB_receptor | 1.13e-03 | 12 | 79 | 2 | IPR000333 | |
| Domain | EGF_CA | 1.78e-03 | 122 | 79 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 1.89e-03 | 124 | 79 | 4 | IPR001881 | |
| Domain | Laminin_G | 1.90e-03 | 58 | 79 | 3 | IPR001791 | |
| Domain | EGF | 2.01e-03 | 126 | 79 | 4 | PF00008 | |
| Domain | Sulfatase_CS | 2.04e-03 | 16 | 79 | 2 | IPR024607 | |
| Domain | SULFATASE_1 | 2.31e-03 | 17 | 79 | 2 | PS00523 | |
| Domain | SULFATASE_2 | 2.31e-03 | 17 | 79 | 2 | PS00149 | |
| Pathway | REACTOME_KERATINIZATION | KRTAP2-3 LELP1 KRT31 KRT32 KRT35 KRTAP2-4 SPRR2D SPRR2G KRTAP3-1 KRTAP2-1 KRTAP16-1 KRT38 LCE2D LCE2C KRT36 LCE3B LCE3A KRTAP10-4 LCE2A KRTAP10-6 LCE2B | 6.53e-24 | 217 | 58 | 21 | M27640 |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | LELP1 KRT31 KRT32 KRT35 SPRR2D SPRR2G KRT38 LCE2D LCE2C KRT36 LCE3B LCE3A LCE2A LCE2B | 1.01e-16 | 129 | 58 | 14 | M27649 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL3A1 EPHB3 KRTAP2-3 COL5A2 LELP1 KRT31 KRT32 KRT35 KRTAP2-4 SPRR2D SPRR2G KRTAP3-1 LAMA2 LAMC1 KRTAP2-1 KRTAP16-1 TET3 KRT38 LCE2D LCE2C KRT36 LCE3B LCE3A NOTCH1 KRTAP10-4 LCE2A KRTAP10-6 LCE2B | 1.71e-13 | 1432 | 58 | 28 | M509 |
| Pathway | REACTOME_KERATINIZATION | KRTAP2-3 KRT31 KRT32 KRT35 KRTAP2-4 KRTAP3-1 KRTAP2-1 KRTAP16-1 KRT36 KRTAP10-4 KRTAP10-6 | 2.52e-11 | 153 | 58 | 11 | MM15343 |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL3A1 EPHB3 KRTAP2-3 COL5A2 KRT31 KRT32 KRT35 KRTAP2-4 KRTAP3-1 KRTAP2-1 KRTAP16-1 KRT36 KRTAP10-4 KRTAP10-6 | 1.06e-08 | 502 | 58 | 14 | MM14537 |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.30e-07 | 30 | 58 | 5 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 6.62e-07 | 41 | 58 | 5 | M27778 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 1.18e-06 | 84 | 58 | 6 | M7098 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 4.18e-06 | 59 | 58 | 5 | M27218 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 7.30e-06 | 66 | 58 | 5 | M18 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.07e-05 | 11 | 58 | 3 | M158 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.46e-05 | 76 | 58 | 5 | M27219 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.77e-05 | 79 | 58 | 5 | M27643 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 1.84e-05 | 13 | 58 | 3 | M47534 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.61e-04 | 199 | 58 | 6 | M7253 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 1.65e-04 | 5 | 58 | 2 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 1.65e-04 | 5 | 58 | 2 | MM14733 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.73e-04 | 68 | 58 | 4 | M27303 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 2.47e-04 | 6 | 58 | 2 | M27068 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.48e-04 | 30 | 58 | 3 | M27216 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 2.48e-04 | 30 | 58 | 3 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 2.48e-04 | 30 | 58 | 3 | MM15812 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 3.30e-04 | 33 | 58 | 3 | M39503 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 3.45e-04 | 7 | 58 | 2 | MM14734 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 3.90e-04 | 84 | 58 | 4 | M3228 | |
| Pathway | KEGG_TGF_BETA_SIGNALING_PATHWAY | 4.26e-04 | 86 | 58 | 4 | M2642 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 4.45e-04 | 87 | 58 | 4 | MM15351 | |
| Pathway | REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES | 4.58e-04 | 8 | 58 | 2 | MM14651 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AMH_SIGNALING_PATHWAY | 5.88e-04 | 9 | 58 | 2 | M47844 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 6.47e-04 | 96 | 58 | 4 | M39834 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 7.26e-04 | 43 | 58 | 3 | M39565 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 8.85e-04 | 46 | 58 | 3 | M239 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 8.85e-04 | 46 | 58 | 3 | M198 | |
| Pathway | PID_ALK2_PATHWAY | 8.93e-04 | 11 | 58 | 2 | M203 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 8.93e-04 | 11 | 58 | 2 | M47865 | |
| Pathway | WP_FOCAL_ADHESION | 1.01e-03 | 187 | 58 | 5 | MM15913 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 1.07e-03 | 12 | 58 | 2 | M47532 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 1.07e-03 | 12 | 58 | 2 | M47533 | |
| Pathway | REACTOME_THE_ACTIVATION_OF_ARYLSULFATASES | 1.26e-03 | 13 | 58 | 2 | M663 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 1.26e-03 | 13 | 58 | 2 | M47423 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.41e-03 | 300 | 58 | 6 | M610 | |
| Pathway | PID_NOTCH_PATHWAY | 1.82e-03 | 59 | 58 | 3 | M17 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 2.44e-03 | 18 | 58 | 2 | M614 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 2.52e-03 | 66 | 58 | 3 | MM15925 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 2.61e-03 | 140 | 58 | 4 | M587 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.72e-03 | 19 | 58 | 2 | MM15512 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.82e-03 | 143 | 58 | 4 | M27275 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 3.01e-03 | 20 | 58 | 2 | MM15061 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 3.01e-03 | 20 | 58 | 2 | M27290 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 3.01e-03 | 20 | 58 | 2 | MM14991 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 3.22e-03 | 72 | 58 | 3 | M39403 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 3.32e-03 | 21 | 58 | 2 | MM15706 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 3.35e-03 | 73 | 58 | 3 | MM15906 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 3.98e-03 | 23 | 58 | 2 | MM14954 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 4.33e-03 | 24 | 58 | 2 | M11190 | |
| Pathway | WP_CLOCKCONTROLLED_AUTOPHAGY_IN_BONE_METABOLISM | 4.34e-03 | 80 | 58 | 3 | M45523 | |
| Pathway | REACTOME_NOTCH3_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 4.70e-03 | 25 | 58 | 2 | M27880 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 5.47e-03 | 27 | 58 | 2 | M39545 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 5.47e-03 | 27 | 58 | 2 | M27217 | |
| Pathway | WP_HAIR_FOLLICLE_DEVELOPMENT_CYTODIFFERENTIATION_STAGE_3_OF_3 | 5.49e-03 | 87 | 58 | 3 | M39465 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 5.87e-03 | 28 | 58 | 2 | M6177 | |
| Pubmed | Assessment of community efforts to advance network-based prediction of protein-protein interactions. | KRTAP2-3 LELP1 KRT31 KRT32 KRT35 KRTAP2-4 KRTAP3-1 KRT38 LCE2D LCE2C KRT36 LCE3B LCE3A KRTAP10-4 LCE2A KRTAP10-6 LCE2B | 1.32e-13 | 630 | 83 | 17 | 36949045 |
| Pubmed | 8.57e-12 | 9 | 83 | 5 | 7686952 | ||
| Pubmed | 1.11e-11 | 22 | 83 | 6 | 15854049 | ||
| Pubmed | Differentially expressed late constituents of the epidermal cornified envelope. | 1.50e-11 | 23 | 83 | 6 | 11698679 | |
| Pubmed | The catalog of human hair keratins. I. Expression of the nine type I members in the hair follicle. | 1.71e-11 | 10 | 83 | 5 | 10391933 | |
| Pubmed | 2.93e-10 | 16 | 83 | 5 | 17410201 | ||
| Pubmed | 5.73e-10 | 18 | 83 | 5 | 11311202 | ||
| Pubmed | Characterization of a 190-kilobase pair domain of human type I hair keratin genes. | 3.76e-09 | 9 | 83 | 4 | 9756910 | |
| Pubmed | 2.81e-08 | 37 | 83 | 5 | 11279113 | ||
| Pubmed | 1.14e-07 | 19 | 83 | 4 | 27234308 | ||
| Pubmed | 1.31e-07 | 5 | 83 | 3 | 11969289 | ||
| Pubmed | 2.18e-07 | 175 | 83 | 7 | 28071719 | ||
| Pubmed | 4.32e-07 | 63 | 83 | 5 | 16831889 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 4.33e-07 | 26 | 83 | 4 | 34189436 | |
| Pubmed | 4.56e-07 | 7 | 83 | 3 | 14557481 | ||
| Pubmed | Abscence of laminin alpha1 chain in the skeletal muscle of dystrophic dy/dy mice. | 4.56e-07 | 7 | 83 | 3 | 9390664 | |
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 9852162 | ||
| Pubmed | 7.28e-07 | 8 | 83 | 3 | 8872465 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 9.03e-07 | 135 | 83 | 6 | 28675934 | |
| Pubmed | 1.09e-06 | 9 | 83 | 3 | 11279051 | ||
| Pubmed | 1.43e-06 | 146 | 83 | 6 | 27068509 | ||
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | FCGBP ARSA KRT31 KRT32 IGHG1 IGHG2 KRT35 LAMA5 LAMC1 MUC5B CR1 KRT38 KRT36 | 1.48e-06 | 1070 | 83 | 13 | 23533145 |
| Pubmed | 1.55e-06 | 10 | 83 | 3 | 9034910 | ||
| Pubmed | Integrin-laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro. | 1.55e-06 | 10 | 83 | 3 | 18590826 | |
| Pubmed | 1.55e-06 | 10 | 83 | 3 | 11784026 | ||
| Pubmed | 1.88e-06 | 153 | 83 | 6 | 25037231 | ||
| Pubmed | 2.13e-06 | 11 | 83 | 3 | 12051813 | ||
| Pubmed | Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch. | 2.13e-06 | 11 | 83 | 3 | 17658279 | |
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 2.13e-06 | 11 | 83 | 3 | 21524702 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 2.13e-06 | 11 | 83 | 3 | 23472759 | |
| Pubmed | 2.58e-06 | 40 | 83 | 4 | 27068110 | ||
| Pubmed | 2.84e-06 | 12 | 83 | 3 | 16750824 | ||
| Pubmed | 2.84e-06 | 12 | 83 | 3 | 18643845 | ||
| Pubmed | 2.84e-06 | 12 | 83 | 3 | 9396756 | ||
| Pubmed | 3.11e-06 | 167 | 83 | 6 | 22159717 | ||
| Pubmed | 3.68e-06 | 13 | 83 | 3 | 36350252 | ||
| Pubmed | Fukutin-related protein alters the deposition of laminin in the eye and brain. | 3.68e-06 | 13 | 83 | 3 | 21900571 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 3.72e-06 | 97 | 83 | 5 | 27559042 | |
| Pubmed | Congenital asplenia in mice and humans with mutations in a Pbx/Nkx2-5/p15 module. | 4.35e-06 | 177 | 83 | 6 | 22560297 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 35964930 | ||
| Pubmed | Notch1 and Notch3 coordinate for pericyte-induced stabilization of vasculature. | 5.63e-06 | 2 | 83 | 2 | 34878922 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 16226104 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 25722188 | ||
| Pubmed | Human alpha 1(III) and alpha 2(V) procollagen genes are located on the long arm of chromosome 2. | 5.63e-06 | 2 | 83 | 2 | 3858826 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 26634853 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 21131365 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 30379609 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 21191019 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 25723053 | ||
| Pubmed | Notch1 regulates maturation of CD4+ and CD8+ thymocytes by modulating TCR signal strength. | 5.63e-06 | 2 | 83 | 2 | 11290335 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 17881497 | ||
| Pubmed | NFX1-123 and human papillomavirus 16E6 increase Notch expression in keratinocytes. | 5.63e-06 | 2 | 83 | 2 | 24109236 | |
| Pubmed | On the regulation of hair keratin expression: lessons from studies in pilomatricomas. | 5.63e-06 | 2 | 83 | 2 | 15140206 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 29023469 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 33851764 | ||
| Pubmed | Sequestration of latent TGF-β binding protein 1 into CADASIL-related Notch3-ECD deposits. | 5.63e-06 | 2 | 83 | 2 | 25190493 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 24728738 | ||
| Pubmed | Distinct roles for Notch1 and Notch3 in human adipose-derived stem/stromal cell adipogenesis. | 5.63e-06 | 2 | 83 | 2 | 33021719 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 26563570 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 14595837 | ||
| Pubmed | Nonoverlapping functions for Notch1 and Notch3 during murine steady-state thymic lymphopoiesis. | 5.63e-06 | 2 | 83 | 2 | 21768299 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 23881612 | ||
| Pubmed | Immunoglobulin GM and KM genotypes in Korean patients with systemic lupus erythematosus. | 5.63e-06 | 2 | 83 | 2 | 16944158 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 25700162 | ||
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 11566270 | ||
| Pubmed | Evidence of Notch pathway activation in the ectatic ducts of chronic pancreatitis. | 5.63e-06 | 2 | 83 | 2 | 18069660 | |
| Pubmed | 5.63e-06 | 2 | 83 | 2 | 16507912 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 5.84e-06 | 15 | 83 | 3 | 15895400 | |
| Pubmed | 5.84e-06 | 15 | 83 | 3 | 10625553 | ||
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 5.84e-06 | 15 | 83 | 3 | 12921739 | |
| Pubmed | 5.84e-06 | 15 | 83 | 3 | 9264260 | ||
| Pubmed | 6.39e-06 | 50 | 83 | 4 | 23658023 | ||
| Pubmed | 7.18e-06 | 16 | 83 | 3 | 19733164 | ||
| Pubmed | 7.18e-06 | 16 | 83 | 3 | 17601529 | ||
| Pubmed | 8.70e-06 | 17 | 83 | 3 | 21983115 | ||
| Pubmed | 1.04e-05 | 18 | 83 | 3 | 14730302 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 1.04e-05 | 18 | 83 | 3 | 39040056 | |
| Pubmed | 1.45e-05 | 20 | 83 | 3 | 22911573 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 15987768 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 31882770 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 7615640 | ||
| Pubmed | Notch receptor expression in human brain arteriovenous malformations. | 1.69e-05 | 3 | 83 | 2 | 25846406 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 7918097 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 8645602 | ||
| Pubmed | Notch/CXCR4 Partnership in Acute Lymphoblastic Leukemia Progression. | 1.69e-05 | 3 | 83 | 2 | 31346528 | |
| Pubmed | PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: a pilot study. | 1.69e-05 | 3 | 83 | 2 | 34846251 | |
| Pubmed | Expression of Notch1 to -4 and their ligands in renal cell carcinoma: a tissue microarray study. | 1.69e-05 | 3 | 83 | 2 | 21471519 | |
| Pubmed | Smooth muscle Notch1 mediates neointimal formation after vascular injury. | 1.69e-05 | 3 | 83 | 2 | 19433762 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 27697639 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 20801121 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 18483410 | ||
| Pubmed | KCTD10 regulates brown adipose tissue thermogenesis and metabolic function via Notch signaling. | 1.69e-05 | 3 | 83 | 2 | 34854382 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 26843448 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 11133776 | ||
| Pubmed | Overlapping but distinct roles for NOTCH receptors in human cardiovascular disease. | 1.69e-05 | 3 | 83 | 2 | 29767458 | |
| Pubmed | Psoriasis-Associated Late Cornified Envelope (LCE) Proteins Have Antibacterial Activity. | 1.69e-05 | 3 | 83 | 2 | 28634035 | |
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 7698746 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 18821675 | ||
| Pubmed | 1.69e-05 | 3 | 83 | 2 | 10481268 | ||
| Pubmed | Expression of laminin chains during myogenic differentiation. | 1.69e-05 | 3 | 83 | 2 | 7510707 | |
| Interaction | HOXA1 interactions | KRTAP2-3 CHRDL2 ZNRF3 KRT31 KRT35 KRTAP2-4 CHRD LAMA5 LTBP1 ODF1 KRT38 LCE2D LCE2C LCE3A NOTCH1 KRTAP10-4 LCE2A NOTCH3 LCE2B | 1.34e-16 | 356 | 80 | 19 | int:HOXA1 |
| Interaction | KRTAP5-2 interactions | KRTAP2-3 LELP1 KRTAP2-4 LCE2D LCE2C LCE3B LCE3A LCE2A KRTAP10-6 LCE2B | 4.94e-14 | 62 | 80 | 10 | int:KRTAP5-2 |
| Interaction | KRTAP4-11 interactions | KRTAP2-3 LELP1 KRTAP2-4 KRTAP3-1 LCE2D LCE2C LCE3B LCE3A LCE2A KRTAP10-6 LCE2B | 7.84e-14 | 92 | 80 | 11 | int:KRTAP4-11 |
| Interaction | LCE1C interactions | KRTAP2-3 KRTAP2-4 CHRD ODF1 LCE2D LCE2C LCE3B LCE3A LCE2A LCE2B | 4.81e-13 | 77 | 80 | 10 | int:LCE1C |
| Interaction | LCE2B interactions | KRTAP2-3 KRTAP2-4 KRTAP3-1 LCE2D LCE2C LCE3B LCE3A LCE2A KRTAP10-6 LCE2B | 8.13e-13 | 81 | 80 | 10 | int:LCE2B |
| Interaction | OTX1 interactions | KRTAP2-3 CHRDL2 KRT31 KRT35 KRTAP2-4 KRTAP3-1 CHRD LCE2D LCE2C KRTAP10-4 LCE2A LCE2B | 1.07e-12 | 155 | 80 | 12 | int:OTX1 |
| Interaction | LCE1B interactions | KRTAP2-3 KRT31 KRTAP2-4 KRTAP3-1 LCE2D LCE2C LCE3B LCE2A KRTAP10-6 LCE2B | 1.34e-12 | 85 | 80 | 10 | int:LCE1B |
| Interaction | KRTAP4-12 interactions | KRTAP2-3 LELP1 KRT31 KRTAP2-4 KRTAP3-1 CHRD LCE2D LCE2C LCE3B LCE3A LCE2A LCE2B | 1.68e-12 | 161 | 80 | 12 | int:KRTAP4-12 |
| Interaction | LCE5A interactions | KRTAP2-3 KRTAP2-4 KRTAP3-1 CHRD LCE2D LCE2C LCE3B LCE2A KRTAP10-6 LCE2B | 2.41e-12 | 90 | 80 | 10 | int:LCE5A |
| Interaction | KRTAP9-8 interactions | KRTAP2-3 KRTAP2-4 KRTAP3-1 LCE2D LCE2C LCE3B LCE3A LCE2A KRTAP10-6 LCE2B | 7.05e-12 | 100 | 80 | 10 | int:KRTAP9-8 |
| Interaction | LCE2A interactions | KRTAP2-3 KRTAP2-4 LCE2D LCE2C LCE3B LCE3A LCE2A KRTAP10-6 LCE2B | 7.20e-12 | 69 | 80 | 9 | int:LCE2A |
| Interaction | KRTAP9-3 interactions | KRTAP2-3 KRT31 KRTAP2-4 KRTAP3-1 CHRD LCE2D LCE2C LCE3B LCE3A LCE2A LCE2B | 8.50e-12 | 140 | 80 | 11 | int:KRTAP9-3 |
| Interaction | LCE3D interactions | KRTAP2-3 KRT31 KRTAP2-4 KRTAP3-1 LCE2D LCE2C LCE2A KRTAP10-6 LCE2B | 1.22e-11 | 73 | 80 | 9 | int:LCE3D |
| Interaction | KRTAP9-2 interactions | KRTAP2-3 LELP1 KRT31 KRTAP2-4 CHRD LCE2D LCE2C LCE3B LCE3A LCE2A LCE2B | 1.68e-11 | 149 | 80 | 11 | int:KRTAP9-2 |
| Interaction | LCE3A interactions | KRTAP2-3 KRTAP2-4 KRTAP3-1 LCE2D LCE2C LCE3B LCE3A LCE2A LCE2B | 1.77e-11 | 76 | 80 | 9 | int:LCE3A |
| Interaction | KRTAP4-4 interactions | KRTAP2-3 KRTAP2-4 LCE2D LCE2C LCE3B LCE3A LCE2A KRTAP10-6 LCE2B | 3.19e-11 | 81 | 80 | 9 | int:KRTAP4-4 |
| Interaction | LCE2C interactions | KRTAP2-3 KRTAP2-4 LCE2D LCE2C LCE3B LCE3A LCE2A KRTAP10-6 LCE2B | 6.83e-11 | 88 | 80 | 9 | int:LCE2C |
| Interaction | LCE1F interactions | KRTAP2-3 KRTAP2-4 CHRD LCE2D LCE2C LCE3B LCE2A KRTAP10-6 LCE2B | 1.03e-10 | 92 | 80 | 9 | int:LCE1F |
| Interaction | KRTAP5-6 interactions | 1.25e-10 | 94 | 80 | 9 | int:KRTAP5-6 | |
| Interaction | KRTAP5-4 interactions | 1.40e-10 | 63 | 80 | 8 | int:KRTAP5-4 | |
| Interaction | KRTAP5-11 interactions | 2.05e-10 | 66 | 80 | 8 | int:KRTAP5-11 | |
| Interaction | LCE1D interactions | 3.33e-10 | 70 | 80 | 8 | int:LCE1D | |
| Interaction | KRTAP5-9 interactions | KRTAP2-3 LELP1 KRTAP2-4 CHRD LCE2D LCE2C LCE3B LCE3A LCE2A KRTAP10-6 LCE2B | 4.72e-10 | 203 | 80 | 11 | int:KRTAP5-9 |
| Interaction | KRTAP10-1 interactions | KRTAP2-3 KRTAP2-4 CHRD LCE2D LCE2C LCE3B LCE3A LCE2A KRTAP10-6 LCE2B | 4.94e-10 | 153 | 80 | 10 | int:KRTAP10-1 |
| Interaction | LCE2D interactions | 5.25e-10 | 74 | 80 | 8 | int:LCE2D | |
| Interaction | KRTAP4-5 interactions | 6.53e-10 | 76 | 80 | 8 | int:KRTAP4-5 | |
| Interaction | VASN interactions | KRTAP2-3 KRT31 KRTAP2-4 KRTAP3-1 LCE2D LCE2C LCE3A LCE2A KRTAP10-6 LCE2B | 7.66e-10 | 160 | 80 | 10 | int:VASN |
| Interaction | KRTAP10-5 interactions | LELP1 KRTAP2-4 CHRD LCE2D LCE2C LCE3B LCE3A LCE2A KRTAP10-6 LCE2B | 7.66e-10 | 160 | 80 | 10 | int:KRTAP10-5 |
| Interaction | LCE4A interactions | 9.92e-10 | 80 | 80 | 8 | int:LCE4A | |
| Interaction | LCE1A interactions | 1.47e-09 | 84 | 80 | 8 | int:LCE1A | |
| Interaction | KRTAP5-3 interactions | 7.67e-09 | 66 | 80 | 7 | int:KRTAP5-3 | |
| Interaction | TRIM42 interactions | 7.68e-09 | 149 | 80 | 9 | int:TRIM42 | |
| Interaction | LCE1E interactions | 9.48e-09 | 68 | 80 | 7 | int:LCE1E | |
| Interaction | LCE3B interactions | 2.67e-08 | 46 | 80 | 6 | int:LCE3B | |
| Interaction | NBPF19 interactions | KRTAP2-3 TROAP KRTAP2-4 CHRD LCE2D LCE2C RECK LCE3A LCE2A LCE2B | 2.85e-08 | 233 | 80 | 10 | int:NBPF19 |
| Interaction | RGS17 interactions | 3.47e-08 | 48 | 80 | 6 | int:RGS17 | |
| Interaction | KRTAP4-2 interactions | 5.34e-08 | 132 | 80 | 8 | int:KRTAP4-2 | |
| Interaction | DMRT3 interactions | 5.38e-08 | 87 | 80 | 7 | int:DMRT3 | |
| Interaction | KRTAP2-3 interactions | 9.92e-08 | 95 | 80 | 7 | int:KRTAP2-3 | |
| Interaction | KRTAP2-4 interactions | 1.51e-07 | 101 | 80 | 7 | int:KRTAP2-4 | |
| Interaction | KRTAP1-1 interactions | 2.13e-07 | 219 | 80 | 9 | int:KRTAP1-1 | |
| Interaction | LCE3C interactions | 2.66e-07 | 67 | 80 | 6 | int:LCE3C | |
| Interaction | NOTCH2NLA interactions | KRTAP2-3 TROAP KRTAP2-4 KRTAP3-1 CHRD LCE2D LCE2C RECK LCE3A LCE2A LCE2B | 3.11e-07 | 381 | 80 | 11 | int:NOTCH2NLA |
| Interaction | KRTAP5-7 interactions | 3.77e-07 | 71 | 80 | 6 | int:KRTAP5-7 | |
| Interaction | KRT86 interactions | 5.24e-07 | 75 | 80 | 6 | int:KRT86 | |
| Interaction | CYSRT1 interactions | KRTAP2-3 KRT31 KRTAP2-4 KRTAP3-1 CHRD LCE2D LCE2C LCE3B RECK LCE3A LCE2A LCE2B | 7.82e-07 | 511 | 80 | 12 | int:CYSRT1 |
| Interaction | POU4F2 interactions | 9.57e-07 | 83 | 80 | 6 | int:POU4F2 | |
| Interaction | KRTAP1-5 interactions | 1.30e-06 | 48 | 80 | 5 | int:KRTAP1-5 | |
| Interaction | KRTAP10-6 interactions | 1.35e-06 | 88 | 80 | 6 | int:KRTAP10-6 | |
| Interaction | HAPLN2 interactions | 1.44e-06 | 49 | 80 | 5 | int:HAPLN2 | |
| Interaction | KRTAP12-4 interactions | 2.15e-06 | 53 | 80 | 5 | int:KRTAP12-4 | |
| Interaction | KRT72 interactions | 3.68e-06 | 59 | 80 | 5 | int:KRT72 | |
| Interaction | LCE3E interactions | 4.00e-06 | 60 | 80 | 5 | int:LCE3E | |
| Interaction | KRTAP10-8 interactions | LELP1 KRTAP3-1 CHRD LCE2D LCE2C LCE3B RECK LCE3A LCE2A LCE2B | 4.14e-06 | 401 | 80 | 10 | int:KRTAP10-8 |
| Interaction | VWC2 interactions | 4.71e-06 | 62 | 80 | 5 | int:VWC2 | |
| Interaction | KRTAP12-1 interactions | 5.10e-06 | 63 | 80 | 5 | int:KRTAP12-1 | |
| Interaction | SPRY1 interactions | 5.26e-06 | 111 | 80 | 6 | int:SPRY1 | |
| Interaction | KRTAP10-11 interactions | 5.51e-06 | 64 | 80 | 5 | int:KRTAP10-11 | |
| Interaction | KRT80 interactions | 5.51e-06 | 64 | 80 | 5 | int:KRT80 | |
| Interaction | NRSN1 interactions | 7.14e-06 | 179 | 80 | 7 | int:NRSN1 | |
| Interaction | KRTAP1-3 interactions | 8.54e-06 | 184 | 80 | 7 | int:KRTAP1-3 | |
| Interaction | ITGB4 interactions | 1.04e-05 | 125 | 80 | 6 | int:ITGB4 | |
| Interaction | CATSPER1 interactions | 1.09e-05 | 126 | 80 | 6 | int:CATSPER1 | |
| Interaction | ZNF672 interactions | 1.29e-05 | 12 | 80 | 3 | int:ZNF672 | |
| Interaction | KRT74 interactions | 1.38e-05 | 37 | 80 | 4 | int:KRT74 | |
| Interaction | KRT6B interactions | 1.42e-05 | 132 | 80 | 6 | int:KRT6B | |
| Interaction | SMCP interactions | 1.56e-05 | 79 | 80 | 5 | int:SMCP | |
| Interaction | ZNF264 interactions | 2.08e-05 | 41 | 80 | 4 | int:ZNF264 | |
| Interaction | KRT76 interactions | 2.10e-05 | 84 | 80 | 5 | int:KRT76 | |
| Interaction | KRT78 interactions | 2.49e-05 | 87 | 80 | 5 | int:KRT78 | |
| Interaction | KRTAP12-3 interactions | 2.52e-05 | 146 | 80 | 6 | int:KRTAP12-3 | |
| Interaction | KRT71 interactions | 2.53e-05 | 43 | 80 | 4 | int:KRT71 | |
| Interaction | KRT3 interactions | 2.63e-05 | 88 | 80 | 5 | int:KRT3 | |
| Interaction | ADAMTSL3 interactions | 2.65e-05 | 15 | 80 | 3 | int:ADAMTSL3 | |
| Interaction | KRTAP17-1 interactions | 3.92e-05 | 48 | 80 | 4 | int:KRTAP17-1 | |
| Interaction | ZNF578 interactions | 3.93e-05 | 17 | 80 | 3 | int:ZNF578 | |
| Interaction | KLHL38 interactions | 4.64e-05 | 99 | 80 | 5 | int:KLHL38 | |
| Interaction | CREB5 interactions | 4.84e-05 | 164 | 80 | 6 | int:CREB5 | |
| Interaction | KRTAP10-9 interactions | 4.85e-05 | 241 | 80 | 7 | int:KRTAP10-9 | |
| Interaction | TSPAN4 interactions | 5.81e-05 | 53 | 80 | 4 | int:TSPAN4 | |
| Interaction | KRT81 interactions | 5.81e-05 | 53 | 80 | 4 | int:KRT81 | |
| Interaction | MAML3 interactions | 6.54e-05 | 20 | 80 | 3 | int:MAML3 | |
| Interaction | JOSD1 interactions | 7.23e-05 | 56 | 80 | 4 | int:JOSD1 | |
| Interaction | NKD1 interactions | 7.61e-05 | 21 | 80 | 3 | int:NKD1 | |
| Interaction | WDR25 interactions | 8.30e-05 | 58 | 80 | 4 | int:WDR25 | |
| Interaction | KRT79 interactions | 8.88e-05 | 59 | 80 | 4 | int:KRT79 | |
| Interaction | ZNF792 interactions | 9.48e-05 | 60 | 80 | 4 | int:ZNF792 | |
| Interaction | MOBP interactions | 1.01e-04 | 23 | 80 | 3 | int:MOBP | |
| Interaction | KRT85 interactions | 1.01e-04 | 61 | 80 | 4 | int:KRT85 | |
| Interaction | RGS20 interactions | 1.07e-04 | 118 | 80 | 5 | int:RGS20 | |
| Interaction | KRT4 interactions | 1.08e-04 | 62 | 80 | 4 | int:KRT4 | |
| Interaction | RSPO2 interactions | 1.15e-04 | 24 | 80 | 3 | int:RSPO2 | |
| Interaction | NTN5 interactions | 1.15e-04 | 24 | 80 | 3 | int:NTN5 | |
| Interaction | SPATA3 interactions | 1.15e-04 | 24 | 80 | 3 | int:SPATA3 | |
| Interaction | NPDC1 interactions | 1.30e-04 | 65 | 80 | 4 | int:NPDC1 | |
| Interaction | ZDHHC1 interactions | 1.30e-04 | 25 | 80 | 3 | int:ZDHHC1 | |
| Interaction | PHLDA1 interactions | 1.38e-04 | 66 | 80 | 4 | int:PHLDA1 | |
| Interaction | CRCT1 interactions | 1.38e-04 | 66 | 80 | 4 | int:CRCT1 | |
| Interaction | BMP2 interactions | 1.47e-04 | 26 | 80 | 3 | int:BMP2 | |
| Interaction | KRT83 interactions | 1.55e-04 | 68 | 80 | 4 | int:KRT83 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q21 | LELP1 SPRR2D SPRR2G SPRR4 PRR9 LCE2D LCE2C LCE3B LCE3A LCE7A LCE2A LCE2B | 1.01e-11 | 404 | 83 | 12 | chr1q21 |
| Cytoband | 1q21.3 | 4.69e-11 | 117 | 83 | 8 | 1q21.3 | |
| Cytoband | 17q12-q21 | 3.31e-09 | 32 | 83 | 5 | 17q12-q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | KRTAP2-3 KRT31 KRT32 KRT35 KRTAP2-4 KRTAP3-1 KRTAP2-1 KRTAP16-1 KRT38 KRT36 | 1.52e-08 | 473 | 83 | 10 | chr17q21 |
| Cytoband | 17q21.2 | 1.89e-07 | 70 | 83 | 5 | 17q21.2 | |
| Cytoband | 1q21-q22 | 7.97e-04 | 23 | 83 | 2 | 1q21-q22 | |
| GeneFamily | Late cornified envelope proteins | 2.28e-11 | 18 | 62 | 6 | 627 | |
| GeneFamily | Keratins, type I | 3.72e-08 | 28 | 62 | 5 | 608 | |
| GeneFamily | Laminin subunits | 6.08e-08 | 12 | 62 | 4 | 626 | |
| GeneFamily | Keratin associated proteins | KRTAP2-3 KRTAP2-4 KRTAP3-1 KRTAP2-1 KRTAP16-1 KRTAP10-4 KRTAP10-6 | 8.92e-08 | 109 | 62 | 7 | 619 |
| GeneFamily | Small proline rich proteins | 6.21e-06 | 11 | 62 | 3 | 1353 | |
| GeneFamily | Sulfatases | 1.71e-03 | 18 | 62 | 2 | 410 | |
| GeneFamily | CD molecules|Mucins | 2.33e-03 | 21 | 62 | 2 | 648 | |
| Coexpression | NABA_CORE_MATRISOME | 1.34e-08 | 275 | 81 | 10 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.71e-07 | 196 | 81 | 8 | M3008 | |
| Coexpression | CAMPS_COLON_CANCER_COPY_NUMBER_UP | 4.44e-07 | 93 | 81 | 6 | M18750 | |
| Coexpression | NABA_MATRISOME | COL3A1 COL5A2 LAMB4 CHRDL2 PXDNL MUC19 LAMA2 KCP CHRD LAMA5 LAMC1 MUC5B LTBP1 HTRA4 SSPOP | 5.08e-07 | 1026 | 81 | 15 | M5889 |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | KRT31 KRT32 IGHG1 IGHG2 KRT35 KRTAP3-1 LAMA2 LAMA5 LTBP1 LCE2D LCE2C NOTCH1 | 5.22e-07 | 630 | 81 | 12 | MM1038 |
| Coexpression | NABA_CORE_MATRISOME | 1.92e-06 | 270 | 81 | 8 | MM17057 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 4.12e-06 | 35 | 81 | 4 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 4.62e-06 | 36 | 81 | 4 | MM1212 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 7.11e-06 | 40 | 81 | 4 | M5887 | |
| Coexpression | NABA_MATRISOME | COL3A1 COL5A2 CHRDL2 MUC19 LAMA2 KCP CHRD LAMA5 LAMC1 MUC5B LTBP1 HTRA4 SSPOP | 1.24e-05 | 1008 | 81 | 13 | MM17056 |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.55e-05 | 16 | 81 | 3 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 1.55e-05 | 16 | 81 | 3 | M2207 | |
| Coexpression | JARDIM_PERASSI_TRIPLE_NEGATIVE_BREAST_CANCER_MOUSE_XENOGRAFT_MELATONIN_UP | 1.61e-05 | 49 | 81 | 4 | MM452 | |
| Coexpression | TANAKA_METHYLATED_IN_ESOPHAGEAL_CARCINOMA | 1.64e-05 | 102 | 81 | 5 | M14455 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.85e-05 | 191 | 81 | 6 | MM17059 | |
| Coexpression | GSE27786_LIN_NEG_VS_ERYTHROBLAST_DN | 3.69e-05 | 200 | 81 | 6 | M4793 | |
| Coexpression | GSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_UP | 3.69e-05 | 200 | 81 | 6 | M4299 | |
| Coexpression | HOLLERN_SQUAMOUS_BREAST_TUMOR | 4.12e-05 | 204 | 81 | 6 | MM966 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 4.82e-05 | 23 | 81 | 3 | M48001 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 6.54e-05 | 569 | 81 | 9 | M12701 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 1.11e-04 | 610 | 81 | 9 | M3854 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 1.40e-04 | 6 | 81 | 2 | M48000 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 1.79e-04 | 650 | 81 | 9 | MM1042 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 2.52e-04 | 681 | 81 | 9 | M39175 | |
| Coexpression | UNTERMAN_PROGRESSIVE_VS_STABLE_IPF_B_CELL_DN | 2.61e-04 | 8 | 81 | 2 | M48298 | |
| Coexpression | MARTENS_TRETINOIN_RESPONSE_UP | NFATC1 KRT35 SPRR4 PRR9 MUC5B ODF1 KRTAP16-1 KRT38 KRT36 NOTCH3 | 3.00e-04 | 855 | 81 | 10 | M2098 |
| Coexpression | GSE16385_IFNG_TNF_VS_IL4_STIM_MACROPHAGE_DN | 3.19e-04 | 191 | 81 | 5 | M8011 | |
| CoexpressionAtlas | skin | EPHB3 LAMB4 KRT31 KRT32 KRT35 ASIP SPRR2G SPRR4 LAMA5 RNF39 LCE2D LCE2C KRT36 LCE2A LCE2B | 7.91e-11 | 456 | 77 | 15 | skin |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 4.70e-05 | 466 | 77 | 9 | GSM777050_500 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | KRTAP2-3 KRT31 KRT32 KRT35 KRTAP3-1 SPRR4 KRTAP2-1 KRTAP16-1 KRT38 KRTAP10-4 KRTAP10-6 | 3.29e-15 | 146 | 82 | 11 | 522c32103c24fc26836bb5b642083904682d9292 |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.71e-11 | 192 | 82 | 9 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.71e-11 | 192 | 82 | 9 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.32e-09 | 133 | 82 | 7 | f7d0763b5eec2db33044d6850fd57462494038c1 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-08 | 191 | 82 | 7 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.70e-08 | 192 | 82 | 7 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-08 | 193 | 82 | 7 | d9c20a092b507c43fcf7ccb04073fecd27d1749c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.45e-08 | 195 | 82 | 7 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-08 | 196 | 82 | 7 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-08 | 196 | 82 | 7 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.99e-08 | 197 | 82 | 7 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.27e-08 | 198 | 82 | 7 | 5e70246a9ce199cb2fb5379912b8ab59456219e4 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 8.56e-08 | 199 | 82 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.45e-07 | 129 | 82 | 6 | cbeeaa554da971ba2e4c4b82c85a1d070a45abb8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.66e-07 | 143 | 82 | 6 | d0ed8c25da1327085e042c2e03cb7503e2c52ce0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.66e-07 | 143 | 82 | 6 | 8900b92a24289204b9ec7baccc11594fec7694f1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-07 | 160 | 82 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.16e-07 | 160 | 82 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | VE-plasma|VE / Condition, Cell_class and T cell subcluster | 9.31e-07 | 177 | 82 | 6 | 0c1cc0834de55717cb4f69d020339060ce2c9a03 | |
| ToppCell | VE-plasma-|VE / Condition, Cell_class and T cell subcluster | 9.31e-07 | 177 | 82 | 6 | 3a3c94cf30012e2aa266bc4d7fe772e45fa90f6d | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 1.03e-06 | 180 | 82 | 6 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.09e-06 | 182 | 82 | 6 | fc4a5bf784705efe7965ce43ac23c2a8e602e90a | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.20e-06 | 185 | 82 | 6 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.41e-06 | 190 | 82 | 6 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.41e-06 | 190 | 82 | 6 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-06 | 190 | 82 | 6 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.41e-06 | 190 | 82 | 6 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.45e-06 | 191 | 82 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.49e-06 | 192 | 82 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.49e-06 | 192 | 82 | 6 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 193 | 82 | 6 | 0a665531d581d4e3941e29d3f95569da8f166447 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.54e-06 | 193 | 82 | 6 | 24ce1f37cca655415410d2403a52d1ebb3332280 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-7|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.56e-06 | 106 | 82 | 5 | 117b53d525be929652fb998e250d7946170fbaf0 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-06 | 194 | 82 | 6 | 2d0cff9dc538a14518741e2a96d9d78442c81a72 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.63e-06 | 195 | 82 | 6 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.63e-06 | 195 | 82 | 6 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.68e-06 | 196 | 82 | 6 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.68e-06 | 196 | 82 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-06 | 197 | 82 | 6 | 85a8f1d18e0dd1d31341f5131eecd217553bf042 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-06 | 197 | 82 | 6 | e8e3ba791dfaa0fab35e0329a5e34376f9ee6143 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-06 | 197 | 82 | 6 | 9b480f9c799a244bfee64487abd8a1bf07c9a3a2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.73e-06 | 197 | 82 | 6 | 2872a78b1be61aa1d50bc9a49294a21e922dc033 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-06 | 198 | 82 | 6 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.79e-06 | 198 | 82 | 6 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | facs-Trachea-3m-Mesenchymal|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.79e-06 | 198 | 82 | 6 | e85ae846e293687fd193f4d565525d8d3bd1faea | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.84e-06 | 199 | 82 | 6 | 9672230aa0bc6a7289050c955f5154ca183a5159 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.84e-06 | 199 | 82 | 6 | e18abe678da293bd01fae55e2f9ab6fdd643d02d | |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-06 | 200 | 82 | 6 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad | |
| ToppCell | distal-mesenchymal-Myofibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.89e-06 | 200 | 82 | 6 | 61854a459385cd9295be37157a8f81a2c227dff3 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.89e-06 | 200 | 82 | 6 | b04831708fa20471a127b87e8db3728b6e729ce8 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.10e-05 | 158 | 82 | 5 | 410fa08c9d880d27e80ec939fa5ba5a41dcb31ab | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.32e-05 | 164 | 82 | 5 | e3983f655cdba308fb192182829f17bef99ce0ba | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.40e-05 | 166 | 82 | 5 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.40e-05 | 166 | 82 | 5 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.40e-05 | 166 | 82 | 5 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.44e-05 | 167 | 82 | 5 | fe3338f99f94c0dac37e3d649dfdce82e4a56022 | |
| ToppCell | Club_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 1.44e-05 | 167 | 82 | 5 | dbdaaeb3bd9139cb008d9fe24ec031fc5628f136 | |
| ToppCell | Bronchial_Biopsy-Immune-T_and_NK|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.48e-05 | 168 | 82 | 5 | 435b2f238fbb3f50427e8cdecf2220615015153c | |
| ToppCell | -Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.52e-05 | 169 | 82 | 5 | 8ebe9a88111c53a09c25a7b6a164a0a17880458d | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.66e-05 | 172 | 82 | 5 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.70e-05 | 173 | 82 | 5 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 176 | 82 | 5 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-05 | 176 | 82 | 5 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.90e-05 | 177 | 82 | 5 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC_prolif|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.06e-05 | 180 | 82 | 5 | 64956a85c404a2ea7e4eaf6f95ebcc52c198b7cc | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.06e-05 | 180 | 82 | 5 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-05 | 182 | 82 | 5 | d179b5deb07c20d49eb6c58d5a65904f8921de3a | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.17e-05 | 182 | 82 | 5 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.23e-05 | 183 | 82 | 5 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.29e-05 | 184 | 82 | 5 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.29e-05 | 184 | 82 | 5 | 102b6f621a5b551e622f97b12d787c080b052a72 | |
| ToppCell | Pericytes-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.29e-05 | 184 | 82 | 5 | 3d2d55d0f22874be21665ab37da710482f77fc36 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.35e-05 | 185 | 82 | 5 | e0c9e92e35fb24351f5347a0768e6aab5add8775 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.35e-05 | 185 | 82 | 5 | 9f19f04fc4d97dfc2dd78cde77b515f1cb5d51ec | |
| ToppCell | normal_Lung-B_lymphocytes-MALT_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 2.41e-05 | 186 | 82 | 5 | f4d72463c5f287da6436287eda0a349b4185841e | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 186 | 82 | 5 | 37860daeecd6d412bd3797f30496a56da667fbd1 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.41e-05 | 186 | 82 | 5 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 186 | 82 | 5 | 60830822d3de3147816693404fd03392e04c2b8e | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-05 | 186 | 82 | 5 | baebeffdd426ce767190ddefc857cc78e6a58d36 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 2.48e-05 | 187 | 82 | 5 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.48e-05 | 187 | 82 | 5 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 2.48e-05 | 187 | 82 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Metaplastic_Carcinoma-2|TCGA-Breast / Sample_Type by Project: Shred V9 | 2.53e-05 | 92 | 82 | 4 | cad8b1b74a412988b2ae4f6126b2186100a2cdc2 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Recurrent_Tumor|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.53e-05 | 92 | 82 | 4 | b728c0faf742c9235b891e3acf34d18a0e335c22 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Recurrent_Tumor-Sarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.53e-05 | 92 | 82 | 4 | 207cde9de6f37b33e47bc6f9c32c9877ab7cbe63 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.54e-05 | 188 | 82 | 5 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.54e-05 | 188 | 82 | 5 | 14bc73cf79c79c9f208369fd8d498e5b26e0114d | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.54e-05 | 188 | 82 | 5 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 188 | 82 | 5 | 7191087d8754f5e8700e3d744cd920ee26db1e57 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 2.60e-05 | 189 | 82 | 5 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-05 | 189 | 82 | 5 | b06471b1bebb990d5146bddfb8002401c6b099a0 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 189 | 82 | 5 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 189 | 82 | 5 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | droplet-Lung-immune-endo-depleted|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 189 | 82 | 5 | c3fb363bb0156ffb3367c200f548faebda64ab4a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.60e-05 | 189 | 82 | 5 | d531399749409d614adca13d181830c6e3287508 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 189 | 82 | 5 | 2a2953f6b1b7d070d739dcaf7285fce6e097d9e4 | |
| ToppCell | SupraBC-Differ-KC|World / shred by cell class for mouse tongue | 2.60e-05 | 189 | 82 | 5 | 6412741b88e241304033b41effca0c77a374d907 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-G_(Club-Clara_cells)|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.60e-05 | 189 | 82 | 5 | a8246acf31f02c85421268245afb651aa8788f14 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.60e-05 | 189 | 82 | 5 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | droplet-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.60e-05 | 189 | 82 | 5 | 5a636e952da9b1fd26aa17f7b129054f2da322b5 | |
| Computational | Neighborhood of CDH11 | 6.34e-05 | 25 | 34 | 3 | GNF2_CDH11 | |
| Computational | Neighborhood of PTX3 | 1.92e-04 | 36 | 34 | 3 | GNF2_PTX3 | |
| Computational | Neighborhood of LTK | 4.00e-04 | 46 | 34 | 3 | GCM_LTK | |
| Computational | Neighborhood of RING1 | 4.07e-04 | 112 | 34 | 4 | GCM_RING1 | |
| Computational | Placenta genes. | 5.14e-04 | 463 | 34 | 7 | MODULE_38 | |
| Computational | Neighborhood of HMGA2 | 5.81e-04 | 123 | 34 | 4 | GCM_HMGA2 | |
| Computational | Adhesion molecules. | 9.69e-04 | 141 | 34 | 4 | MODULE_122 | |
| Computational | Keratin. | 3.01e-03 | 26 | 34 | 2 | MODULE_298 | |
| Computational | Genes in the cancer module 68. | 3.01e-03 | 26 | 34 | 2 | MODULE_68 | |
| Computational | Genes in the cancer module 97. | 3.58e-03 | 98 | 34 | 3 | MODULE_97 | |
| Computational | Genes in the cancer module 379. | 3.74e-03 | 204 | 34 | 4 | MODULE_379 | |
| Computational | Heart, liver, kidney and pancreas metabolic and xenobiotic response genes. | 3.78e-03 | 835 | 34 | 8 | MODULE_88 | |
| Computational | Genes in the cancer module 182. | 3.79e-03 | 100 | 34 | 3 | MODULE_182 | |
| Computational | Neighborhood of SMARCD1 | 4.35e-03 | 105 | 34 | 3 | GCM_SMARCD1 | |
| Computational | Genes in the cancer module 242. | 4.44e-03 | 214 | 34 | 4 | MODULE_242 | |
| Drug | AC1L1I0J | 5.98e-09 | 19 | 82 | 5 | CID000004371 | |
| Drug | AC1L1G72 | 5.06e-08 | 11 | 82 | 4 | CID000003553 | |
| Drug | Vistar | 1.85e-07 | 36 | 82 | 5 | CID000040896 | |
| Drug | Calcort | 2.45e-07 | 38 | 82 | 5 | CID000026709 | |
| Drug | 9-(5',5'-difluoro-5'-phosphonopentyl)guanine | 6.54e-07 | 46 | 82 | 5 | CID000448999 | |
| Drug | NSC34533 | 1.47e-06 | 54 | 82 | 5 | CID000003512 | |
| Drug | LG 5 | 2.50e-06 | 60 | 82 | 5 | CID011840957 | |
| Drug | AC1L1B58 | 3.47e-06 | 29 | 82 | 4 | CID000001288 | |
| Drug | sulfur mustard | 7.57e-06 | 130 | 82 | 6 | CID000010461 | |
| Drug | 2-amino-5-methylpyridine | 8.64e-06 | 77 | 82 | 5 | CID000015348 | |
| Drug | YIGSR | 9.80e-06 | 79 | 82 | 5 | CID000123977 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 1.25e-05 | 83 | 82 | 5 | CID011968896 | |
| Drug | NSC 714187 | 1.40e-05 | 85 | 82 | 5 | CID005288693 | |
| Drug | al-Badry | 2.94e-05 | 165 | 82 | 6 | CID000004545 | |
| Drug | Norakin | 3.84e-05 | 3 | 82 | 2 | CID000161077 | |
| Drug | kalinin | 4.63e-05 | 55 | 82 | 4 | CID000032518 | |
| Drug | DOPAC | 5.31e-05 | 112 | 82 | 5 | CID000000547 | |
| Drug | CK17 | 5.34e-05 | 57 | 82 | 4 | CID000128831 | |
| Drug | TAAD | 5.71e-05 | 21 | 82 | 3 | CID000133445 | |
| Drug | ALT-711 | 5.71e-05 | 21 | 82 | 3 | CID000216304 | |
| Drug | CC270 | 6.12e-05 | 59 | 82 | 4 | CID006918852 | |
| Drug | SD-208 | 7.57e-05 | 23 | 82 | 3 | CID010316032 | |
| Drug | desethylaprindine | 7.65e-05 | 4 | 82 | 2 | CID000162697 | |
| Drug | Budesonide [51333-22-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 7.67e-05 | 196 | 82 | 6 | 6330_DN | |
| Drug | teleocidin B | 8.30e-05 | 123 | 82 | 5 | CID000072425 | |
| Drug | butyrate | WDR19 COL3A1 LAMB4 KRT31 KRT32 KRT35 LAMA2 LAMA5 LAMC1 KRT38 KRT36 | 9.36e-05 | 767 | 82 | 11 | CID000000264 |
| Drug | homocysteine thiolactone | 1.12e-04 | 131 | 82 | 5 | CID000107712 | |
| Drug | tartryl diazide | 1.27e-04 | 5 | 82 | 2 | CID000193925 | |
| Drug | dermatan sulfate | 1.44e-04 | 220 | 82 | 6 | CID000032756 | |
| Drug | dysprosium | 1.48e-04 | 74 | 82 | 4 | CID000023912 | |
| Drug | podocarpic acid | 1.90e-04 | 6 | 82 | 2 | CID000093017 | |
| Drug | 5-dehydrosparteine | 1.90e-04 | 6 | 82 | 2 | CID000160614 | |
| Disease | psoriasis, COVID-19 | 6.37e-06 | 2 | 75 | 2 | EFO_0000676, MONDO_0100096 | |
| Disease | laminin measurement | 3.81e-05 | 4 | 75 | 2 | EFO_0020528 | |
| Disease | Myositis, Proliferative | 6.34e-05 | 5 | 75 | 2 | C0544796 | |
| Disease | Myositis | 6.34e-05 | 5 | 75 | 2 | C0027121 | |
| Disease | Infectious Myositis | 6.34e-05 | 5 | 75 | 2 | C0158353 | |
| Disease | Myositis, Focal | 6.34e-05 | 5 | 75 | 2 | C0751357 | |
| Disease | Idiopathic Inflammatory Myopathies | 6.34e-05 | 5 | 75 | 2 | C0751356 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 1.33e-04 | 7 | 75 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 1.33e-04 | 7 | 75 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | Ehlers-Danlos syndrome | 1.77e-04 | 8 | 75 | 2 | cv:C0013720 | |
| Disease | immunoglobulin isotype switching measurement | 1.94e-04 | 44 | 75 | 3 | EFO_0010128 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 2.27e-04 | 9 | 75 | 2 | DOID:13359 (is_implicated_in) | |
| Disease | chronic lymphocytic leukemia | 2.45e-04 | 119 | 75 | 4 | EFO_0000095 | |
| Disease | response to corticosteroid, age at assessment | 2.83e-04 | 10 | 75 | 2 | EFO_0008007, GO_0031960 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 3.37e-04 | 53 | 75 | 3 | C4707243 | |
| Disease | Malignant neoplasm of skin | 4.63e-04 | 59 | 75 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 4.63e-04 | 59 | 75 | 3 | C0037286 | |
| Disease | Connective Tissue Diseases | 4.88e-04 | 13 | 75 | 2 | C0009782 | |
| Disease | Impaired cognition | 5.69e-04 | 14 | 75 | 2 | C0338656 | |
| Disease | cholangiocarcinoma (is_marker_for) | 5.88e-04 | 64 | 75 | 3 | DOID:4947 (is_marker_for) | |
| Disease | juvenile idiopathic arthritis | 8.98e-04 | 74 | 75 | 3 | EFO_0002609 | |
| Disease | ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn's disease, sclerosing cholangitis | 9.41e-04 | 295 | 75 | 5 | EFO_0000384, EFO_0000676, EFO_0000729, EFO_0003898, EFO_0004268 | |
| Disease | Glioblastoma | 1.09e-03 | 79 | 75 | 3 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 1.30e-03 | 84 | 75 | 3 | C0334588 | |
| Disease | congenital heart disease (is_implicated_in) | 1.70e-03 | 24 | 75 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | Carcinoma, Pancreatic Ductal | 1.70e-03 | 24 | 75 | 2 | C0887833 | |
| Disease | Cerebral Astrocytoma | 1.84e-03 | 25 | 75 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 1.84e-03 | 25 | 75 | 2 | C0750936 | |
| Disease | Pilocytic Astrocytoma | 1.84e-03 | 25 | 75 | 2 | C0334583 | |
| Disease | Astrocytoma | 1.84e-03 | 25 | 75 | 2 | C0004114 | |
| Disease | Juvenile Pilocytic Astrocytoma | 1.84e-03 | 25 | 75 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 1.84e-03 | 25 | 75 | 2 | C0280785 | |
| Disease | Grade I Astrocytoma | 1.84e-03 | 25 | 75 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 1.84e-03 | 25 | 75 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 1.84e-03 | 25 | 75 | 2 | C0547065 | |
| Disease | Childhood Cerebral Astrocytoma | 1.84e-03 | 25 | 75 | 2 | C0338070 | |
| Disease | Squamous cell carcinoma of esophagus | 1.85e-03 | 95 | 75 | 3 | C0279626 | |
| Disease | brain cancer (implicated_via_orthology) | 1.99e-03 | 26 | 75 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | Gemistocytic astrocytoma | 1.99e-03 | 26 | 75 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 1.99e-03 | 26 | 75 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 1.99e-03 | 26 | 75 | 2 | C0334582 | |
| Disease | hair shape measurement | 2.15e-03 | 27 | 75 | 2 | EFO_0007824 | |
| Disease | Anaplastic astrocytoma | 2.15e-03 | 27 | 75 | 2 | C0334579 | |
| Disease | obesity (implicated_via_orthology) | 2.22e-03 | 215 | 75 | 4 | DOID:9970 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CKTPPSPGQAVECCQ | 81 | Q04771 | |
| AVCSPPVLCSCPGPS | 1301 | Q9P1Z9 | |
| CPRGCPPLCPEDCTS | 521 | Q16671 | |
| TRNSCKPPAPACCDP | 96 | P42127 | |
| KPPAPACCDPCASCQ | 101 | P42127 | |
| CKPLPCDAQGQPPPC | 5446 | Q9HC84 | |
| PCCCSIPQPCRGSGP | 551 | O95153 | |
| KPIIPPGACCPLCAG | 816 | O95980 | |
| PKCLPCPSQSPSSCP | 56 | Q5T871 | |
| KCPSSCPHACPPPCP | 81 | Q5T871 | |
| PCSPSPCQNGGTCRP | 221 | P46531 | |
| NACSKPIGPCLSNPC | 376 | Q15323 | |
| PIGPCLSNPCTSCVP | 381 | Q15323 | |
| TSCVPPAPCTPCAPR | 391 | Q15323 | |
| GPCPPCPKMVTTTCY | 276 | Q6ZNB6 | |
| CAGHPPPPSPQACVC | 6 | Q5FYB0 | |
| CVPRTVGMPCSPCPQ | 431 | Q14532 | |
| CVTAPCAPRPSCGPC | 426 | O76015 | |
| SPCCRPPCGQPTPCS | 106 | P0C7H8 | |
| CPPPCCKPDTYVPTC | 51 | Q9BYR8 | |
| PGSQRCTKPSCVPPC | 181 | Q14766 | |
| CTKPSCVPPCQNGGM | 186 | Q14766 | |
| DCKPEECPSPPTCKT | 8191 | Q7Z5P9 | |
| PCWTPCSPKGCPAET | 426 | Q9NST1 | |
| QEPTCLQPCSPACPP | 856 | O95644 | |
| CESAPGQLPVCSCPQ | 786 | Q9UM47 | |
| SCNLLCHPGPCPPCP | 456 | Q12986 | |
| EPAAKESQCRPCPPG | 276 | P54753 | |
| SPCCRPPCGQPTPCS | 106 | Q9BYU5 | |
| PTKGTSEDCQPCACP | 796 | P24043 | |
| SPCCRPPCGQPTPCS | 106 | Q9BYR9 | |
| KSCLPCLPAASCGPS | 421 | Q92764 | |
| PGCTPRPACCHCPDP | 491 | P15289 | |
| PSAPCVSCPCPLSVP | 1906 | O15230 | |
| SCKDGAPQVCPIPPE | 1066 | Q9Y5S2 | |
| PAPLPLPDSCCQACK | 161 | Q6WN34 | |
| CSPCNPCSPYDPCNP | 221 | Q14990 | |
| PPELQPPTNCCMSGC | 81 | Q5BKU9 | |
| CYCPPPPCQEAISKE | 36 | Q96BW5 | |
| PCSSVCTNDPPCFPM | 831 | A1KZ92 | |
| TQPSCPAVCQPTRCP | 36 | P83105 | |
| SGPAPQCIIPNKCTP | 226 | P17927 | |
| SGPAPQCIIPNKCTP | 676 | P17927 | |
| SGPAPQCIIPNKCTP | 1126 | P17927 | |
| GECVSKPCPSPCTPE | 2241 | Q9Y6R7 | |
| CGECVSKPCPSPCTP | 3441 | Q9Y6R7 | |
| CPPGSAGCIPSDKCP | 3836 | Q9Y6R7 | |
| PPGQCKAPCISCTPD | 766 | Q53EP0 | |
| GCCQAPEQPPQPLCP | 246 | Q9UF56 | |
| LCPGSNDPCVEKPCP | 3791 | Q8TDW7 | |
| VTPPGECCPVCSQTP | 86 | P05997 | |
| NPSSGQPCRPCLCPD | 901 | A4D0S4 | |
| PCCPVTCEPSPCQSG | 66 | P60372 | |
| PCCPVTCEPSPCQSG | 66 | P60371 | |
| QCPAPCPPPVSSCCG | 31 | Q5TA79 | |
| KCLPQCPAPCSPAVS | 31 | O14633 | |
| KCPPQCPAPCFPAVS | 31 | Q5TA81 | |
| KCPPQCPAPCSPAVS | 31 | Q5TA82 | |
| CPAKSPAQCLPPASS | 16 | Q5TA76 | |
| CPSPKCPPKSSAQCL | 16 | Q5TA77 | |
| SCPAPCPPPAPSCCV | 31 | P0DV60 | |
| QPCPCPGGSSCAVVP | 771 | P11047 | |
| PVVCEPSCCQPVCPT | 221 | A8MUX0 | |
| VKRCPSVCPEPVSCP | 336 | A8MUX0 | |
| FGECCAVCPQPPTAP | 81 | P02461 | |
| ECPPAHTCPCGVPAC | 11 | Q8N1N5 | |
| ECPPAHTCPCGVPAC | 371 | Q8N1N5 | |
| KSCDKTHTCPPCPAP | 101 | P01857 | |
| KCCVECPPCPAPPVA | 101 | P01859 | |
| DCKLPPQPCATACKP | 401 | O76013 | |
| VIPQGVAPSPCIPCC | 876 | Q8IWE5 | |
| PEPSACSEPGECPAK | 286 | Q2TAK8 | |
| VPPLTPCPAPCFCKT | 336 | Q8IW52 | |
| PCPAPCFCKTHPSDL | 341 | Q8IW52 | |
| GPYCPIPCNCKVLSP | 326 | Q9H5Y7 | |
| PEGQCVPPSLCPCQL | 871 | A2VEC9 | |
| KPCPQDGCPNATCSG | 1801 | A2VEC9 | |
| DLCQKGLVPPCPPSC | 2626 | A2VEC9 | |
| SPCGPPCPRSCDDLV | 3321 | A2VEC9 | |
| QPCPQPSCPPLCLQG | 4206 | A2VEC9 | |
| CQDLPPCQPGCYCPK | 4451 | A2VEC9 | |
| QPCPECPPGQVLSAC | 4816 | A2VEC9 | |
| CAPCASAPCAPAPAA | 111 | Q15270 | |
| SCTPPGECCPICRPG | 181 | Q6ZWJ8 | |
| GSVQCEPLPCPPVPC | 341 | Q6ZWJ8 | |
| GVPKCGAVLCPPAPC | 456 | Q6ZWJ8 | |
| APCAHPLPGTCCPND | 586 | Q6ZWJ8 | |
| CCPQCPAAPAPAGCP | 656 | Q6ZWJ8 | |
| PPGSCCPVCRAPTQS | 1136 | Q6ZWJ8 | |
| APALSPGSCCPRCLP | 1196 | Q6ZWJ8 | |
| ACPVACPVGCPAACP | 41 | O95177 | |
| CPVGCPAACPVGCPI | 46 | O95177 | |
| PAACPVGCPIACPVS | 51 | O95177 | |
| ACPVSCPVACPVGCP | 61 | O95177 | |
| EQCKTCPGCPQEPAS | 451 | Q8TE82 | |
| PECELLCPGCKNSIP | 1261 | Q8NEZ3 | |
| NIKPECPTPACGQPR | 101 | Q9H2X0 | |
| PVQAPDQCCPVCPEK | 751 | Q9H2X0 | |
| PPTPPCPTCGFRCCT | 231 | Q8N8E2 | |
| KNCCEVLCGPLPPSV | 281 | Q9Y397 | |
| GVPFSCCNPHSPRPC | 211 | Q03395 | |
| PCQPPPVKCQETCAP | 26 | Q96PI1 | |
| CPSPKCPQPCPPQQC | 36 | P22532 | |
| CPPEHCPPPPCQDKC | 41 | Q9BYE4 | |
| PKPCLPEECGEPQPC | 501 | Q12815 | |
| PCVPPPCLPKTQEQC | 11 | Q5T870 | |
| GMKPPNCNCDGPECP | 266 | O43151 | |
| CPAPCQTTYVKCPTP | 91 | Q5T750 | |
| ACCCEPQPSPAGPSA | 711 | Q9ULT6 | |
| PAPPAQLPCPQCSKS | 436 | Q8TF50 | |
| ASPTACPCCGLPCPR | 126 | Q9H2S5 | |
| PASCKSPRPSCGPLC | 1056 | Q9Y493 | |
| LCCECGVPISPNPAN | 16 | Q96D46 |